nodes	percent_of_prediction	percent_of_DWPC	metapath
Vapreotide—TACR1—Spinal Cord Injury—ROS1—kidney cancer	0.0565	0.0579	CbGpPWpGaD
Vapreotide—SSTR2—SIDS Susceptibility Pathways—HSPD1—kidney cancer	0.0224	0.023	CbGpPWpGaD
Vapreotide—SSTR2—SIDS Susceptibility Pathways—IL13—kidney cancer	0.0188	0.0193	CbGpPWpGaD
Vapreotide—TACR1—SIDS Susceptibility Pathways—HSPD1—kidney cancer	0.0177	0.0181	CbGpPWpGaD
Vapreotide—TACR1—Spinal Cord Injury—ANXA1—kidney cancer	0.0167	0.0171	CbGpPWpGaD
Vapreotide—SSTR5—Peptide ligand-binding receptors—ANXA1—kidney cancer	0.0157	0.0161	CbGpPWpGaD
Vapreotide—SSTR5—GPCR downstream signaling—OR4C13—kidney cancer	0.0153	0.0157	CbGpPWpGaD
Vapreotide—Desmopressin—PTGS1—kidney cancer	0.0151	0.636	CrCbGaD
Vapreotide—TACR1—SIDS Susceptibility Pathways—IL13—kidney cancer	0.0148	0.0152	CbGpPWpGaD
Vapreotide—SSTR2—Peptide ligand-binding receptors—ANXA1—kidney cancer	0.0145	0.0149	CbGpPWpGaD
Vapreotide—SSTR2—SIDS Susceptibility Pathways—EGR1—kidney cancer	0.0143	0.0146	CbGpPWpGaD
Vapreotide—SSTR2—GPCR downstream signaling—OR4C13—kidney cancer	0.0142	0.0145	CbGpPWpGaD
Vapreotide—TACR1—Spinal Cord Injury—EGR1—kidney cancer	0.014	0.0144	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—OR4C13—kidney cancer	0.0139	0.0143	CbGpPWpGaD
Vapreotide—TACR1—G alpha (q) signalling events—ITPR2—kidney cancer	0.0138	0.0141	CbGpPWpGaD
Vapreotide—SSTR5—G alpha (i) signalling events—ANXA1—kidney cancer	0.0133	0.0136	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—OR4C13—kidney cancer	0.0129	0.0132	CbGpPWpGaD
Vapreotide—TACR1—Gastrin-CREB signalling pathway via PKC and MAPK—ITPR2—kidney cancer	0.0124	0.0127	CbGpPWpGaD
Vapreotide—SSTR2—G alpha (i) signalling events—ANXA1—kidney cancer	0.0122	0.0125	CbGpPWpGaD
Vapreotide—TACR1—G alpha (q) signalling events—ANXA1—kidney cancer	0.0116	0.0119	CbGpPWpGaD
Vapreotide—TACR1—Peptide ligand-binding receptors—ANXA1—kidney cancer	0.0114	0.0117	CbGpPWpGaD
Vapreotide—TACR1—SIDS Susceptibility Pathways—EGR1—kidney cancer	0.0112	0.0115	CbGpPWpGaD
Vapreotide—TACR1—GPCR downstream signaling—OR4C13—kidney cancer	0.0111	0.0114	CbGpPWpGaD
Vapreotide—SSTR5—Class A/1 (Rhodopsin-like receptors)—ANXA1—kidney cancer	0.0106	0.0108	CbGpPWpGaD
Vapreotide—TACR1—Gastrin-CREB signalling pathway via PKC and MAPK—ANXA1—kidney cancer	0.0104	0.0106	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—OR4C13—kidney cancer	0.0101	0.0104	CbGpPWpGaD
Vapreotide—SSTR2—SIDS Susceptibility Pathways—HIF1A—kidney cancer	0.00993	0.0102	CbGpPWpGaD
Vapreotide—SSTR2—Class A/1 (Rhodopsin-like receptors)—ANXA1—kidney cancer	0.00974	0.00997	CbGpPWpGaD
Vapreotide—Desmopressin—PTGS2—kidney cancer	0.00861	0.364	CrCbGaD
Vapreotide—SSTR5—Signaling Pathways—OR4C13—kidney cancer	0.00823	0.00843	CbGpPWpGaD
Vapreotide—SSTR5—GPCR ligand binding—ANXA1—kidney cancer	0.00803	0.00823	CbGpPWpGaD
Vapreotide—TACR1—SIDS Susceptibility Pathways—HIF1A—kidney cancer	0.00782	0.00801	CbGpPWpGaD
Vapreotide—SSTR5—Peptide ligand-binding receptors—POMC—kidney cancer	0.00771	0.00789	CbGpPWpGaD
Vapreotide—TACR1—Class A/1 (Rhodopsin-like receptors)—ANXA1—kidney cancer	0.00767	0.00785	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—OR4C13—kidney cancer	0.0076	0.00778	CbGpPWpGaD
Vapreotide—SSTR2—GPCR ligand binding—ANXA1—kidney cancer	0.00741	0.00759	CbGpPWpGaD
Vapreotide—SSTR2—Peptide ligand-binding receptors—POMC—kidney cancer	0.00711	0.00728	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—LATS1—kidney cancer	0.007	0.00717	CbGpPWpGaD
Vapreotide—TACR1—Spinal Cord Injury—PTGS2—kidney cancer	0.00654	0.0067	CbGpPWpGaD
Vapreotide—SSTR5—G alpha (i) signalling events—POMC—kidney cancer	0.0065	0.00666	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—LATS1—kidney cancer	0.00646	0.00662	CbGpPWpGaD
Vapreotide—SSTR5—GPCR downstream signaling—AKAP13—kidney cancer	0.00637	0.00653	CbGpPWpGaD
Vapreotide—TACR1—Spinal Cord Injury—CDKN1B—kidney cancer	0.00619	0.00634	CbGpPWpGaD
Vapreotide—TACR1—Spinal Cord Injury—IL2—kidney cancer	0.00606	0.00621	CbGpPWpGaD
Vapreotide—SSTR2—G alpha (i) signalling events—POMC—kidney cancer	0.006	0.00615	CbGpPWpGaD
Vapreotide—SSTR2—SIDS Susceptibility Pathways—JUN—kidney cancer	0.00599	0.00613	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—OR4C13—kidney cancer	0.00598	0.00613	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—AMER1—kidney cancer	0.00595	0.0061	CbGpPWpGaD
Vapreotide—SSTR2—SIDS Susceptibility Pathways—CTNNB1—kidney cancer	0.00594	0.00609	CbGpPWpGaD
Vapreotide—TACR1—Spinal Cord Injury—CCND1—kidney cancer	0.00591	0.00605	CbGpPWpGaD
Vapreotide—SSTR2—GPCR downstream signaling—AKAP13—kidney cancer	0.00588	0.00602	CbGpPWpGaD
Vapreotide—TACR1—GPCR ligand binding—ANXA1—kidney cancer	0.00584	0.00598	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—AKAP13—kidney cancer	0.00579	0.00593	CbGpPWpGaD
Vapreotide—TACR1—Peptide ligand-binding receptors—POMC—kidney cancer	0.0056	0.00573	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—AMER1—kidney cancer	0.00549	0.00563	CbGpPWpGaD
Vapreotide—SSTR5—GPCR downstream signaling—ITPR2—kidney cancer	0.00542	0.00555	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—AKAP13—kidney cancer	0.00534	0.00547	CbGpPWpGaD
Vapreotide—SSTR2—SIDS Susceptibility Pathways—VEGFA—kidney cancer	0.00523	0.00536	CbGpPWpGaD
Vapreotide—SSTR5—Class A/1 (Rhodopsin-like receptors)—POMC—kidney cancer	0.00517	0.00529	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—LATS1—kidney cancer	0.00509	0.00521	CbGpPWpGaD
Vapreotide—SSTR2—GPCR downstream signaling—ITPR2—kidney cancer	0.005	0.00512	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—GPC3—kidney cancer	0.00499	0.00511	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—CER1—kidney cancer	0.00499	0.00511	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—ITPR2—kidney cancer	0.00492	0.00504	CbGpPWpGaD
Vapreotide—TACR1—Spinal Cord Injury—MAPK3—kidney cancer	0.00487	0.00499	CbGpPWpGaD
Vapreotide—SSTR2—Class A/1 (Rhodopsin-like receptors)—POMC—kidney cancer	0.00477	0.00489	CbGpPWpGaD
Vapreotide—TACR1—Spinal Cord Injury—MYC—kidney cancer	0.00474	0.00485	CbGpPWpGaD
Vapreotide—TACR1—SIDS Susceptibility Pathways—JUN—kidney cancer	0.00471	0.00483	CbGpPWpGaD
Vapreotide—TACR1—SIDS Susceptibility Pathways—CTNNB1—kidney cancer	0.00468	0.00479	CbGpPWpGaD
Vapreotide—TACR1—Spinal Cord Injury—MAPK1—kidney cancer	0.00464	0.00475	CbGpPWpGaD
Vapreotide—TACR1—GPCR downstream signaling—AKAP13—kidney cancer	0.00463	0.00474	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—CER1—kidney cancer	0.0046	0.00471	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—GPC3—kidney cancer	0.0046	0.00471	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—ITPR2—kidney cancer	0.00454	0.00465	CbGpPWpGaD
Vapreotide—SSTR5—GPCR downstream signaling—ANXA1—kidney cancer	0.00454	0.00465	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—AMER1—kidney cancer	0.00432	0.00443	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—SFRP2—kidney cancer	0.00424	0.00434	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—AKAP13—kidney cancer	0.0042	0.00431	CbGpPWpGaD
Vapreotide—SSTR2—GPCR downstream signaling—ANXA1—kidney cancer	0.00419	0.00429	CbGpPWpGaD
Vapreotide—TACR1—Gastrin-CREB signalling pathway via PKC and MAPK—RAF1—kidney cancer	0.00418	0.00428	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—ANXA1—kidney cancer	0.00412	0.00422	CbGpPWpGaD
Vapreotide—TACR1—SIDS Susceptibility Pathways—VEGFA—kidney cancer	0.00412	0.00422	CbGpPWpGaD
Vapreotide—TACR1—GPCR downstream signaling—ITPR2—kidney cancer	0.00394	0.00403	CbGpPWpGaD
Vapreotide—SSTR5—GPCR ligand binding—POMC—kidney cancer	0.00394	0.00403	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—SFRP2—kidney cancer	0.00391	0.00401	CbGpPWpGaD
Vapreotide—TACR1—Spinal Cord Injury—TP53—kidney cancer	0.00389	0.00399	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—ANXA1—kidney cancer	0.00381	0.0039	CbGpPWpGaD
Vapreotide—TACR1—Class A/1 (Rhodopsin-like receptors)—POMC—kidney cancer	0.00376	0.00385	CbGpPWpGaD
Vapreotide—SSTR2—GPCR ligand binding—POMC—kidney cancer	0.00363	0.00372	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—CER1—kidney cancer	0.00362	0.00371	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—GPC3—kidney cancer	0.00362	0.00371	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—ITPR2—kidney cancer	0.00357	0.00366	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—AKAP13—kidney cancer	0.00342	0.0035	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—CASP2—kidney cancer	0.00342	0.0035	CbGpPWpGaD
Vapreotide—TACR1—GPCR downstream signaling—ANXA1—kidney cancer	0.0033	0.00338	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—AKAP13—kidney cancer	0.00315	0.00323	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—CASP2—kidney cancer	0.00315	0.00323	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—GRB7—kidney cancer	0.00313	0.0032	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—SFRP2—kidney cancer	0.00308	0.00316	CbGpPWpGaD
Vapreotide—TACR1—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK3—kidney cancer	0.00301	0.00309	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—ANXA1—kidney cancer	0.003	0.00307	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—ITPR2—kidney cancer	0.00291	0.00298	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—GRB7—kidney cancer	0.00289	0.00296	CbGpPWpGaD
Vapreotide—TACR1—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—kidney cancer	0.00287	0.00294	CbGpPWpGaD
Vapreotide—TACR1—GPCR ligand binding—POMC—kidney cancer	0.00286	0.00293	CbGpPWpGaD
Vapreotide—TACR1—G alpha (q) signalling events—PIK3CA—kidney cancer	0.00278	0.00285	CbGpPWpGaD
Vapreotide—TACR1—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—kidney cancer	0.00271	0.00277	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—ITPR2—kidney cancer	0.00268	0.00275	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—CTNNA1—kidney cancer	0.00264	0.0027	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—EIF4EBP1—kidney cancer	0.00262	0.00268	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—HSPB1—kidney cancer	0.00262	0.00268	CbGpPWpGaD
Vapreotide—TACR1—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—kidney cancer	0.00249	0.00255	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—CASP2—kidney cancer	0.00248	0.00254	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—AKAP13—kidney cancer	0.00248	0.00254	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—TSC1—kidney cancer	0.00244	0.00249	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—ANXA1—kidney cancer	0.00244	0.00249	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—PSMD7—kidney cancer	0.00244	0.00249	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—CTNNA1—kidney cancer	0.00243	0.00249	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—EIF4EBP1—kidney cancer	0.00242	0.00248	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—HSPB1—kidney cancer	0.00242	0.00248	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—FLT1—kidney cancer	0.00236	0.00242	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—GRB7—kidney cancer	0.00227	0.00233	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—TSC1—kidney cancer	0.00225	0.0023	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—ANXA1—kidney cancer	0.00225	0.0023	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—PSMD7—kidney cancer	0.00225	0.0023	CbGpPWpGaD
Vapreotide—SSTR5—GPCR downstream signaling—POMC—kidney cancer	0.00222	0.00228	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—JUNB—kidney cancer	0.00219	0.00224	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—PAK1—kidney cancer	0.00219	0.00224	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—FLT1—kidney cancer	0.00218	0.00223	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—ITPR2—kidney cancer	0.00211	0.00216	CbGpPWpGaD
Vapreotide—SSTR2—GPCR downstream signaling—POMC—kidney cancer	0.00205	0.0021	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—POMC—kidney cancer	0.00202	0.00207	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—PAK1—kidney cancer	0.00202	0.00207	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—JUNB—kidney cancer	0.00202	0.00207	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—CTNNA1—kidney cancer	0.00191	0.00196	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—EIF4EBP1—kidney cancer	0.0019	0.00195	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—HSPB1—kidney cancer	0.0019	0.00195	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—POMC—kidney cancer	0.00186	0.00191	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—IGF2—kidney cancer	0.00179	0.00183	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—CDKN2B—kidney cancer	0.00178	0.00182	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—PSMD7—kidney cancer	0.00177	0.00181	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—ANXA1—kidney cancer	0.00177	0.00181	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—TSC1—kidney cancer	0.00177	0.00181	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—IGF1R—kidney cancer	0.00173	0.00177	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—FLT1—kidney cancer	0.00171	0.00176	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—RAF1—kidney cancer	0.00167	0.00171	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—IGF2—kidney cancer	0.00165	0.00169	CbGpPWpGaD
Vapreotide—SSTR5—GPCR downstream signaling—IL2—kidney cancer	0.00164	0.00168	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—CDKN2B—kidney cancer	0.00164	0.00168	CbGpPWpGaD
Vapreotide—TACR1—GPCR downstream signaling—POMC—kidney cancer	0.00162	0.00166	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—IGF1R—kidney cancer	0.0016	0.00163	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—PAK1—kidney cancer	0.00159	0.00163	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—JUNB—kidney cancer	0.00159	0.00163	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—RAF1—kidney cancer	0.00154	0.00157	CbGpPWpGaD
Vapreotide—SSTR2—GPCR downstream signaling—IL2—kidney cancer	0.00152	0.00155	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—IL2—kidney cancer	0.00149	0.00153	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—POMC—kidney cancer	0.00147	0.0015	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—HIF1A—kidney cancer	0.00142	0.00146	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—TSC2—kidney cancer	0.00142	0.00145	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—IL2—kidney cancer	0.00138	0.00141	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—KDR—kidney cancer	0.00136	0.00139	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—HIF1A—kidney cancer	0.00131	0.00135	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—TSC2—kidney cancer	0.00131	0.00134	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—IGF2—kidney cancer	0.0013	0.00133	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—CDKN2B—kidney cancer	0.00129	0.00132	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—KDR—kidney cancer	0.00126	0.00129	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—IGF1R—kidney cancer	0.00126	0.00129	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—KIT—kidney cancer	0.00125	0.00128	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—APC—kidney cancer	0.00125	0.00128	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—RAF1—kidney cancer	0.00121	0.00124	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—MAPK3—kidney cancer	0.0012	0.00123	CbGpPWpGaD
Vapreotide—TACR1—GPCR downstream signaling—IL2—kidney cancer	0.00119	0.00122	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—POMC—kidney cancer	0.00119	0.00122	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—BRAF—kidney cancer	0.00118	0.00121	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—KIT—kidney cancer	0.00116	0.00118	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—APC—kidney cancer	0.00116	0.00118	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—MAPK1—kidney cancer	0.00114	0.00117	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—MAPK3—kidney cancer	0.00111	0.00113	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—POMC—kidney cancer	0.0011	0.00113	CbGpPWpGaD
Vapreotide—SSTR5—GPCR downstream signaling—PIK3CA—kidney cancer	0.00109	0.00112	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—BRAF—kidney cancer	0.00109	0.00111	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—IL2—kidney cancer	0.00109	0.00111	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—KRAS—kidney cancer	0.00108	0.00111	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—MAPK1—kidney cancer	0.00105	0.00108	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—HIF1A—kidney cancer	0.00103	0.00106	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—TSC2—kidney cancer	0.00103	0.00106	CbGpPWpGaD
Vapreotide—SSTR2—GPCR downstream signaling—PIK3CA—kidney cancer	0.00101	0.00103	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—KRAS—kidney cancer	0.000996	0.00102	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—PIK3CA—kidney cancer	0.000991	0.00102	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—KDR—kidney cancer	0.000989	0.00101	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—RAF1—kidney cancer	0.000984	0.00101	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—RELA—kidney cancer	0.00098	0.001	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—ERBB2—kidney cancer	0.000973	0.000997	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—MTOR—kidney cancer	0.000961	0.000984	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—PIK3CA—kidney cancer	0.000915	0.000937	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—APC—kidney cancer	0.000911	0.000933	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—KIT—kidney cancer	0.000911	0.000933	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—RAF1—kidney cancer	0.000908	0.00093	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—RELA—kidney cancer	0.000904	0.000926	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—CDKN1B—kidney cancer	0.000901	0.000923	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—ERBB2—kidney cancer	0.000898	0.00092	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—MTOR—kidney cancer	0.000886	0.000908	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—IL2—kidney cancer	0.000882	0.000904	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—MAPK3—kidney cancer	0.000872	0.000893	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—POMC—kidney cancer	0.000867	0.000888	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—CCND1—kidney cancer	0.00086	0.000881	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—JUN—kidney cancer	0.000858	0.000879	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—BRAF—kidney cancer	0.000856	0.000877	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—CTNNB1—kidney cancer	0.000852	0.000872	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—CDKN1B—kidney cancer	0.000832	0.000852	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—PTEN—kidney cancer	0.00083	0.00085	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—MAPK1—kidney cancer	0.00083	0.00085	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—IL2—kidney cancer	0.000814	0.000834	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—CCND1—kidney cancer	0.000794	0.000813	CbGpPWpGaD
Vapreotide—TACR1—GPCR downstream signaling—PIK3CA—kidney cancer	0.000793	0.000812	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—JUN—kidney cancer	0.000792	0.000811	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—CTNNB1—kidney cancer	0.000786	0.000805	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—KRAS—kidney cancer	0.000784	0.000803	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—PTEN—kidney cancer	0.000766	0.000785	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—VEGFA—kidney cancer	0.00075	0.000768	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—PIK3CA—kidney cancer	0.00072	0.000738	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—RAF1—kidney cancer	0.000715	0.000732	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—RELA—kidney cancer	0.000712	0.000729	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—MAPK3—kidney cancer	0.000709	0.000726	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—ERBB2—kidney cancer	0.000707	0.000724	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—MTOR—kidney cancer	0.000698	0.000715	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—VEGFA—kidney cancer	0.000692	0.000709	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—MYC—kidney cancer	0.00069	0.000707	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—MAPK1—kidney cancer	0.000675	0.000691	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—CDKN1B—kidney cancer	0.000655	0.000671	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—MAPK3—kidney cancer	0.000655	0.00067	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—IL2—kidney cancer	0.000641	0.000657	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—KRAS—kidney cancer	0.000637	0.000653	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—MYC—kidney cancer	0.000637	0.000652	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—CCND1—kidney cancer	0.000625	0.00064	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—JUN—kidney cancer	0.000624	0.000639	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—MAPK1—kidney cancer	0.000623	0.000638	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—CTNNB1—kidney cancer	0.000619	0.000634	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—PTEN—kidney cancer	0.000603	0.000618	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—KRAS—kidney cancer	0.000588	0.000602	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—PIK3CA—kidney cancer	0.000586	0.0006	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—TP53—kidney cancer	0.000566	0.00058	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—VEGFA—kidney cancer	0.000545	0.000558	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—PIK3CA—kidney cancer	0.00054	0.000554	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—TP53—kidney cancer	0.000523	0.000535	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—MAPK3—kidney cancer	0.000515	0.000528	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—MYC—kidney cancer	0.000501	0.000513	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—MAPK1—kidney cancer	0.00049	0.000502	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—KRAS—kidney cancer	0.000463	0.000474	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—PIK3CA—kidney cancer	0.000425	0.000436	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—TP53—kidney cancer	0.000412	0.000422	CbGpPWpGaD
